Lobbying Activity Report

5150-40694

Designated Filer name: Steve Vander Wal
Client: Coloplast Canada Corporation
Associated registration: 2215-5150-2
Lobbying Activity date: 2025-03-14
Arranged a meeting: Yes
Posted date: 2025-03-17

Senior Public Office Holders who were lobbied in this activity: John Capelli, Executive Director
Pharmaceutical Policy, Legislation & Engagement Branch, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Advocate for reimbursement of laryngectomy supplies and how to improve quality of life for laryngectomy patients
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
 Health
Date Modified: